COVID-19 business disruption fuels digital acceleration in life sciences

Most leading life sciences companies were already on the path toward digitization when COVID-19 hit. Then they had to accelerate their original timeline for process automation projects, taking them from several years to just a few months. In order to gain efficiencies, avoid product shortages, and keep costs down, companies began investing heavily in supporting their remote workforce and automating items such as: workflow management, manufacturing, and supply chain. The need to accelerate the development of bespoke solutions increased as well.

In this podcast, KPMG and Appian will share examples of innovative technology solutions being developed with leading life sciences clients and how this is helping to give them a competitive edge. We’ll discuss how they expedited process automation and what we can expect in the year ahead.